Literature DB >> 20380970

Endovascular management of cerebral vasospasm.

Ben McGuinness1, Dheeraj Gandhi.   

Abstract

Cerebral vasospasm is a cause of significant morbidity and mortality in patients with subarachnoid hemorrhage (SAH). Most cases of vasospasm can be managed medically. Medical strategies for treatment include hemodynamic augmentation to improve cerebral perfusion pressure and medical therapy to prevent or reduce cerebral vasospasm. In patients with acute neurological deterioration, imaging assessment is essential to triage those patients appropriate for aggressive medical or endovascular therapy. Such imaging assessment can be performed with many radiologic techniques such as transcranial Doppler, computed tomography (CT), magnetic resonance imaging, and single-photon emission CT (SPECT). Advanced CT applications like CT angiography and CT perfusion are gaining popularity and playing an increasingly important role in the decision making. Endovascular techniques for treatment of vasospasm include intra-arterial administration of vasodilators and intracranial angioplasty. This article discusses the use of these endovascular techniques in the management of vasospasm and provides a current review of literature. Sustained efficacy of intra-arterial vasodilators is less well established at this time, and repeated treatments may be necessary. Balloon angioplasty is an effective technique in treating vasospasm and results in durable clinical improvement. It should be used judiciously, however, given a small risk of vessel rupture associated with intracranial angioplasty. The goal of angioplasty should be improvement of vessel caliber to augment flow rather than to achieve a picture-perfect result. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380970     DOI: 10.1016/j.nec.2009.10.007

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  6 in total

1.  Intra-arterial dantrolene for refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Shahram Majidi; Mikayel Grigoryan; Wondwossen G Tekle; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 2.  Diagnosis of cerebral vasospasm and risk of delayed cerebral ischemia related to aneurysmal subarachnoid haemorrhage: an overview of available tools.

Authors:  Susanna Bacigaluppi; Gianluigi Zona; Francesca Secci; Gianantonio Spena; Nicola Mavilio; Giulia Brusa; Ronit Agid; Timo Krings; Gianandrea Ottonello; Marco Fontanella
Journal:  Neurosurg Rev       Date:  2015-03-04       Impact factor: 3.042

3.  High risk of new episode of symptomatic vasospasm in unaffected arteries in subarachnoid hemorrhage patients receiving targeted endovascular treatment for symptomatic focal vasospasm.

Authors:  Wondwossen G Tekle; Saqib A Chaudry; Ameer E Hassan; Habib Qaiser; Mikayel Grigoryan; Gustavo J Rodriguez; Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

4.  A decade after International Subarachnoid Aneurysm Trial: Coiling as a first choice treatment in the management of intracranial aneurysms - Technical feasibility and early management outcomes.

Authors:  Gaurav Goel; Vipul Gupta; Swati Chinchure; Aditya Gupta; Gurmeen Kaur; Ajaya N Jha
Journal:  Asian J Neurosurg       Date:  2014 Jul-Sep

5.  Prolonged Cerebral Circulation Time Is the Best Parameter for Predicting Vasospasm during Initial CT Perfusion in Subarachnoid Hemorrhagic Patients.

Authors:  Chun Fu Lin; Sanford P C Hsu; Chung Jung Lin; Wan Yuo Guo; Chih Hsiang Liao; Wei Fa Chu; Sheng Che Hung; Yang Shin Shih; Yen Tzu Lin
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

6.  Feasibility of Real-Time Angiographic Perfusion Imaging in the Treatment of Cerebral Vasospasm.

Authors:  Christopher Donaldson; Anthea H O'Neill; Lee-Anne Slater; Winston Chong; Leon T Lai; Ronil V Chandra
Journal:  Interv Neurol       Date:  2017-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.